Rescue of an orphan drug points to a new model for therapies for rare diseases
In a world-first, the Italian research charity Telethon will manufacture and distribute a gene therapy for an inherited immunodeficiency that was dropped by the industry. In a world-first, the Italian research charity Telethon will manufacture and distribute a gene therapy for an inherited immunodeficiency that was dropped by the industry.